Rodney L. Dunn

19.7k total citations · 3 hit papers
279 papers, 14.0k citations indexed

About

Rodney L. Dunn is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Rodney L. Dunn has authored 279 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Pulmonary and Respiratory Medicine, 87 papers in Surgery and 58 papers in Urology. Recurrent topics in Rodney L. Dunn's work include Prostate Cancer Diagnosis and Treatment (79 papers), Bladder and Urothelial Cancer Treatments (47 papers) and Prostate Cancer Treatment and Research (47 papers). Rodney L. Dunn is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (79 papers), Bladder and Urothelial Cancer Treatments (47 papers) and Prostate Cancer Treatment and Research (47 papers). Rodney L. Dunn collaborates with scholars based in United States, United Kingdom and Canada. Rodney L. Dunn's co-authors include John T. Wei, Martin G. Sanda, James E. Montie, Howard M. Sandler, Mark S. Litwin, Brent K. Hollenbeck, David C. Miller, David A. Taub, David P. Wood and Cheryl T. Lee and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Rodney L. Dunn

268 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

2008 1.7k citations Martin G. Sanda, Rodney L. Dunn et al. profile →
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

2000 1.2k citations John T. Wei, Rodney L. Dunn et al. Urology profile →
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment

2015 271 citations Scott A. Tomlins, Javed Siddiqui et al. profile →

Peers

Rodney L. Dunn

PRM

SURGE

ONCOL

UROLO

Peter C. Albertsen United States

David F. Penson United States

Quoc‐Dien Trinh United States

Adam S. Kibel United States

Christopher S. Saigal United States

Janet L. Stanford United States

Jim C. Hu United States

Badrinath R. Konety United States

Matthew R. Cooperberg United States

Judd W. Moul United States

Peter C. Albertsen United States

Rodney L. Dunn

11.3k ×1.7

PRM

3.3k ×0.7

SURGE

3.8k ×1.2

ONCOL

2.5k ×0.9

UROLO

1.4k ×0.7

Citations per year, relative to Rodney L. Dunn Rodney L. Dunn (= 1×) peers Peter C. Albertsen

Countries citing papers authored by Rodney L. Dunn

Since Specialization

Citations

This map shows the geographic impact of Rodney L. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodney L. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodney L. Dunn more than expected).

Fields of papers citing papers by Rodney L. Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodney L. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodney L. Dunn. The network helps show where Rodney L. Dunn may publish in the future.

Co-authorship network of co-authors of Rodney L. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Rodney L. Dunn. A scholar is included among the top collaborators of Rodney L. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodney L. Dunn. Rodney L. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vickers, Andrew J., Melissa Assel, Rodney L. Dunn, et al.. (2025). Guidelines for meta‐analyses and systematic reviews in urology. British Journal of Urology. 136(5). 775–780.

Vickers, Andrew J., Melissa Assel, Rodney L. Dunn, et al.. (2023). Guidelines for reporting observational research in urology: the importance of clear reference to causality. British Journal of Urology. 132(1). 4–8. 3 indexed citations

Tosoian, Jeffrey J., Rodney L. Dunn, Yashar S. Niknafs, et al.. (2021). Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study. European Urology Open Science. 29. 30–35. 2 indexed citations

Filson, Christopher P., John M. Hollingsworth, Chang He, et al.. (2016). Patient-Reported Convalescence and Quality of Life Recovery. Surgical Innovation. 23(6). 598–605. 10 indexed citations

Sarma, Aruna V., James M. Hotaling, Rodney L. Dunn, et al.. (2014). Poor Glycemic Control is Associated with Reduced Prostate Specific Antigen Concentrations in Men with Type 1 Diabetes. The Journal of Urology. 193(3). 786–793. 15 indexed citations

Suskind, Anne M., J. Quentin Clemens, Rodney L. Dunn, et al.. (2013). Effectiveness of Mesh Compared With Nonmesh Sling Surgery in Medicare Beneficiaries. Obstetrics and Gynecology. 122(3). 546–552. 8 indexed citations

Filson, Christopher P., Bruce G. Redman, Rodney L. Dunn, & David C. Miller. (2011). Initial Patterns of Care With Oral Targeted Therapies for Patients With Renal Cell Carcinoma. Urology. 77(4). 825–830.e1. 17 indexed citations

Sauver, Jennifer L. St., Aruna V. Sarma, John M. Hollingsworth, et al.. (2011). Associations Between Modest Weight Changes and Onset and Progression of Lower Urinary Tract Symptoms in Two Population-based Cohorts. Urology. 78(2). 437–441. 9 indexed citations

Hollingsworth, John M., Rodney L. Dunn, Zaojun Ye, & Brent K. Hollenbeck. (2009). RACIAL DIFFERENCES IN TREATMENT AND OUTCOMES AMONG PATIENTS WITH EARLY STAGE BLADDER CANCER. The Journal of Urology. 181(4). 690–690. 1 indexed citations

10.

Ignatoski, Kathleen M. Woods, June Escara‐Wilke, Xiaohua Zhang, et al.. (2008). Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy. Journal of Interferon & Cytokine Research. 29(2). 105–111. 22 indexed citations

11.

Miller, David C., Stephanie Daignault, J. Stuart Wolf, et al.. (2008). Hospital Characteristics and Use of Innovative Surgical Therapies Among Patients With Kidney Cancer. Medical Care. 46(4). 372–379. 27 indexed citations

12.

Bradford, Timothy, Alon Z. Weizer, Scott M. Gilbert, et al.. (2008). Is residual neurovascular tissue on prostatectomy specimens associated with surgeon intent at nerve-sparing and postoperative quality of life measures?. Urologic Oncology Seminars and Original Investigations. 28(5). 487–491. 10 indexed citations

13.

Loberg, Robert D., et al.. (2006). Inhibition of Decay-Accelerating Factor (CD55) Attenuates Prostate Cancer Growth and Survival In Vivo. Neoplasia. 8(1). 69–78. 62 indexed citations

14.

Henry, N. Lynn, Rodney L. Dunn, Quintin Pan, et al.. (2006). Phase II Trial of Copper Depletion with Tetrathiomolybdate as an Antiangiogenesis Strategy in Patients with Hormone-Refractory Prostate Cancer. Oncology. 71(3-4). 168–175. 68 indexed citations

15.

Hollenbeck, Brent K., David A. Taub, David C. Miller, Rodney L. Dunn, & John T. Wei. (2006). National utilization trends of partial nephrectomy for renal cell carcinoma: A case of underutilization?. Urology. 67(2). 254–259. 261 indexed citations

16.

Swain, Jason E., Rodney L. Dunn, Daniel McConnell, Janis González‐Martínez, & Gary D. Smith. (2004). Direct Effects of Leptin on Mouse Reproductive Function: Regulation of Follicular, Oocyte, and Embryo Development. Biology of Reproduction. 71(5). 1446–1452. 80 indexed citations

17.

Hollenbeck, Brent K., John T. Wei, Martin G. Sanda, Rodney L. Dunn, & Howard M. Sandler. (2004). Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer. Urology. 63(5). 946–950. 18 indexed citations

18.

Smith, David C., Christopher H. Chay, Rodney L. Dunn, et al.. (2003). Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone‐refractory prostate carcinoma. Cancer. 98(2). 269–276. 30 indexed citations

19.

Lu, Qing, et al.. (2002). Regulation of Spindle Formation by Active Mitogen-Activated Protein Kinase and Protein Phosphatase 2A During Mouse Oocyte Meiosis1. Biology of Reproduction. 66(1). 29–37. 46 indexed citations

20.

Connolly, Denise C., David L. Greenspan, Rong Wu, et al.. (2000). Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.. PubMed. 6(9). 3505–10. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact